Home > Products > CD33 & CD64
> Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Diabody-CH3)
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-115)
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-CD33 and anti-CD64 antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Diabody-CH3) (BSDBC-115). Click the button below to contact us or submit your feedback about this product.